WT1 and acute myeloid leukemia: We concurrently treated the 3 previously described AML cell lines with VEN +/− WT1-CTLs, thereby aiming to potentially activate both the intrinsic apoptotic pathway (VEN) and the extrinsic apoptotic pathway (CTLs) simultaneously.